Search

Your search keyword '"Hellings, Peter W."' showing total 785 results

Search Constraints

Start Over You searched for: Author "Hellings, Peter W." Remove constraint Author: "Hellings, Peter W."
785 results on '"Hellings, Peter W."'

Search Results

201. Nasal symptoms, epithelial injury and neurogenic inflammation in elite swimmers

202. Rhinology Future Debates 2017 by EUFOREA: Novel treatments and surgical solutions in rhinology

204. Atopic Comorbidities and Biomarkers of Type 2 Inflammation in Patients With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP) Who Failed Intranasal Corticosteroids

206. European Summit on the Prevention and Self-Management of Chronic Respiratory Diseases: report of the European Union Parliament Summit (29 March 2017)

207. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis : A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement

208. Allergen immunotherapy for allergic rhinoconjunctivitis : A systematic overview of systematic reviews

209. Non-allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology.

210. Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report.

211. TRPV4 activation triggers protective responses to bacterial lipopolysaccharides in airway epithelial cells

212. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis: A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement

213. Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic overview of systematic reviews

214. Erratum to: Allergen immunotherapy for allergic rhinoconjunctivitis: Protocol for a systematic review (Clinical and Translational Allergy (2016) 6 (12) DOI: 10.1186/s13601-016-0099-6)

215. MACVIA Clinical Decision Algorithm in Allergic Rhinitis in adolescents and adults

217. TRPV4 activation triggers protective responses to bacterial lipopolysaccharides in airway epithelial cells

218. Resumen ejecutivo de ARIA 2016: vías integradas de atención para la medicina predictiva a lo largo del ciclo de vida en Argentina

220. Abstracts from the 11th Symposium on Experimental Rhinology and Immunology of the Nose (SERIN 2017)

224. Dupilumab Improves Sense of Smell and Reduces Anosmia Among Patients with Nasal Polyposis and Chronic Sinusitis: Results from a Phase 2a Trial

225. Uncontrolled rhinosinusitis

227. The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life.

229. The Global Allergy and Asthma European Network (GALEN) rhinosinusitis cohort: a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps.

230. Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall document.

232. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

233. AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation.

234. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

235. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

236. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

237. Precision medicine in patients with allergic diseases:Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology

238. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

239. Impaired barrier function in patients with house dust mite–induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression

240. Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology

241. List of Contributors

243. Improvement of nasal breathing and patient satisfaction by the endonasal dilator Airmax®

244. SCUAD and chronic rhinosinusitis. Reinforcing hypothesis driven research in difficult cases

246. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

248. Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis—PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology

249. Histamine Receptor H1–Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome

250. Impaired barrier function in patients with house dust mite–induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression

Catalog

Books, media, physical & digital resources